Abstract:Objectives: This animal study tested the spatial learning memory of "depressed" rats undergoing electroconvulsive therapy (ECT) or ECT combined with propofol and aimed to reveal the glutamatergic mechanisms in the hippocampus. Methods: Sixty Sprague-Dawley rats were randomly divided into 5 groups (n = 12 rats per group): control group, depression group, propofol group, ECT group, and propofol + ECT group. Rats were stressed repeatedly for 21 days to establish depression model. After the model was set up, rats of the propofol group were administrated with propofol (100 mg/kg). Rats of ECT group were administered ECT once on alternate days for 2 weeks. ECT + propofol group rats were given ECT after anesthesia with propofol (100 mg/kg). Spatial memory was assessed by Morris water maze. Glutamate content in hippocampus was measured by chromatometry. N-methyl D-aspartate (NMDA)-NR2B expression was detected by immunohistochemistry. Results: After treatment, the behavior level of rats in ECT group and ECT + propofol group was higher than that in depression group, and there was no significance between ECT group and ECT + propofol group. The evasive latency of rats detected by Morris water maze got shorter and shorter from the first day to fourth day. The evasive latency in ECT group was longer than that in ECT + propofol group and depression group, and the evasive latency in ECT + propofol group was shorter than that in depression group. Glutamate contents in hippocampus of rats in depression group and propofol group were higher than those in other groups, and glutamate content in ECT group was lower than that in other groups. The content in ECT + propofol group was lower than that in depression group, but higher than that in ECT group. N-methyl D-aspartate-NR2B expression in hippocampus of rats in depression group was lower than that in control group, but the expressions in ECT group and ECT + propofol group were higher than that in control group, and the expression in ECT + propofol group was lower than that in ECT group. Conclusions: The glutamate content in hippocampus of depressed rats heightens, and the NMDA-NR2B expression down-regulated, which may cause "depression" symptoms and learning memory impairment. After ECT, the glutamate contents decreased, and NMDA-NR2B expression up-regulated, the depression symptoms improved, and the spatial memory worsened simultaneously. However, propofol inhibited the excessive decrease of glutamate and excessive up-regulation of NMDA-NR2B caused by ECT, and both the depression symptoms and the spatial memory of depressed rats improved.

Effects of electroconvulsive therapy and propofol on spatial memory and glutamatergic system in hippocampus of depressed rats.

Effects of propofol combined with electroconvulsive therapy on glutamate content in hippocampus and corpus striatum in mentally depressed rats

Effects of propofol pretreatment on the levels of glutamate and gamma-aminobutyric acid in hippocampus of mentally depressed rats after electro-convulsive therapy

Effect of MECT on learning memory in depressed rats and its synaptic plasticity mechanism

Propofol Prevents Electroconvulsive-Shock-induced Memory Impairment Through Regulation of Hippocampal Synaptic Plasticity in a Rat Model of Depression.

Effect of electroconvulsive therapy and propofol combined with electroconvulsive therapy on brain-derived neurotrophic factor mRNA in hippocampus of depressed rats

Propofol Protects Against Impairment of Learning-Memory and Imbalance of Hippocampal Glu/GABA Induced by Electroconvulsive Shock in Depressed Rats

Effect of propofol anesthesia on electroconvulsive therapy-induced hyperphosphorylation of Tau protein in hippocampus in depressed rats

Propofol Interacts with Stimulus Intensities of Electroconvulsive Shock to Regulate Behavior and Hippocampal BDNF in a Rat Model of Depression.

Effects of different anesthesia depth on learning memory in depressed patients undergoing electroconvulsive therapy

Relationship of modified electroconvulsive therapy and gamma-aminobutyric acid pathway in the hippocampus of depressed rats

Electroconvulsive therapy combined with esketamine improved depression through PI3K/AKT/GLT-1 pathway

Comparison of Effects of Propofol Combined with Different Doses of Esketamine for ECT in the Treatment of Depression: A Randomized Controlled Trial Protocol

Effects of N-Methyl-D-aspartate receptor (NMDAR) and Ca2+/ calmodulin-dependent protein kinase IIα (CaMKIIα) on learning and memory impairment in depressed rats with different charge by modified electroconvulsive shock

The study of cognitive function and synaptic plasticity in depressed rats following electroconvulsive shock

Ciprofol ameliorates ECS-induced learning and memory impairment by modulating aerobic glycolysis in the hippocampus of depressive-like rats

Effect of Ketamine on LTP and NMDAR EPSC in Hippocampus of the Chronic Social Defeat Stress Mice Model of Depression.

Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression

Effects of Electroconvulsive Stimulation on Long-Term Potentiation and Synaptophysin in the Hippocampus of Rats with Depressive Behavior

Effectiveness of propofol in anesthetic management and cognitive function in schizophrenic patients undergoing convulsion-free modified electroconvulsive therapy

Etomidate Improves the Antidepressant Effect of Electroconvulsive Therapy by Suppressing Hippocampal Neuronal Ferroptosis via Upregulating BDNF/Nrf2